A Clinical Trial for CTD-ILD Treatment

Stopped early · Phase 2/Phase 3

Conditions studied: Interstitial Lung Disease, Connective Tissue Disease

In brief

The first objective of this protocol is to assess the tolerability and safety of N-acetylcysteine (NAC) in patients with connective tissue disease related interstitial lung disease (CTD-ILD).

Key facts

Study ID

NCT01424033

Run by

University of Michigan

People needed

5

Starts

2011-12-01

Last updated by the study team

2017-04-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Michigan — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.